Supplementary Materials - Serum proteomics of insulin resistance disorders distinguish MASLD from lipodystrophy and insulin receptor defects

Published: 14 November 2025| Version 1 | DOI: 10.17632/xwfwgngxvf.1
Contributors:
, Allison Wing, Brent Abel, Maren Podszun, Rebecca Brown, Yaron Rotman

Description

Supplementary Materials for Mironova et al, Serum proteomics of insulin resistance disorders distinguish MASLD from lipodystrophy and insulin receptor defects Journal of Clinical Endocrinology & Metabolism, 2025 https://doi.org/10.1210/clinem/dgaf516

Files

Institutions

  • National Institute of Diabetes and Digestive and Kidney Diseases

Categories

Proteomics, Non-Alcoholic Fatty Liver Disease, Liver Disease, Lipodystrophy, Insulin Resistance, Steatosis

Funders

Licence